PL4093383T3 - Transdermalny system terapeutyczny z substancją czynną stanowiącą rotygotynę i co najmniej jednym klejem silikonowym nieodpornym na działanie amin - Google Patents

Transdermalny system terapeutyczny z substancją czynną stanowiącą rotygotynę i co najmniej jednym klejem silikonowym nieodpornym na działanie amin

Info

Publication number
PL4093383T3
PL4093383T3 PL21702196.3T PL21702196T PL4093383T3 PL 4093383 T3 PL4093383 T3 PL 4093383T3 PL 21702196 T PL21702196 T PL 21702196T PL 4093383 T3 PL4093383 T3 PL 4093383T3
Authority
PL
Poland
Prior art keywords
rotigotine
amine
silicone adhesive
therapeutic system
transdermal therapeutic
Prior art date
Application number
PL21702196.3T
Other languages
English (en)
Inventor
Christian Benda
Ulrike KOLLING
Björn Schurad
Gabriel WAUER
Original Assignee
Luye Pharma Switzerland Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luye Pharma Switzerland Ag filed Critical Luye Pharma Switzerland Ag
Publication of PL4093383T3 publication Critical patent/PL4093383T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL21702196.3T 2020-01-24 2021-01-22 Transdermalny system terapeutyczny z substancją czynną stanowiącą rotygotynę i co najmniej jednym klejem silikonowym nieodpornym na działanie amin PL4093383T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20153621.6A EP3854388B1 (de) 2020-01-24 2020-01-24 Transdermales therapeutisches system mit dem wirkstoff rotigotin und mindestens einem nicht aminresistenten silikonkleber
PCT/EP2021/051500 WO2021148634A1 (de) 2020-01-24 2021-01-22 Transdermales therapeutisches system mit dem wirkstoff rotigotin und mindestens einem nicht aminresistenten silikonkleber

Publications (1)

Publication Number Publication Date
PL4093383T3 true PL4093383T3 (pl) 2026-03-09

Family

ID=69191982

Family Applications (2)

Application Number Title Priority Date Filing Date
PL20153621.6T PL3854388T3 (pl) 2020-01-24 2020-01-24 Transdermalny system terapeutyczny z substancją czynną rotygotyną i co najmniej jednym klejem silikonowym nieodpornym na działanie amin
PL21702196.3T PL4093383T3 (pl) 2020-01-24 2021-01-22 Transdermalny system terapeutyczny z substancją czynną stanowiącą rotygotynę i co najmniej jednym klejem silikonowym nieodpornym na działanie amin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL20153621.6T PL3854388T3 (pl) 2020-01-24 2020-01-24 Transdermalny system terapeutyczny z substancją czynną rotygotyną i co najmniej jednym klejem silikonowym nieodpornym na działanie amin

Country Status (19)

Country Link
US (1) US20230218539A1 (pl)
EP (2) EP3854388B1 (pl)
JP (1) JP7835678B2 (pl)
KR (1) KR20220131941A (pl)
CN (1) CN115279351B (pl)
AU (1) AU2021210611B2 (pl)
BR (1) BR112022014665A2 (pl)
CA (1) CA3165453A1 (pl)
CL (1) CL2022001988A1 (pl)
CO (1) CO2022011900A2 (pl)
DK (2) DK3854388T3 (pl)
ES (2) ES2966170T3 (pl)
FI (2) FI3854388T3 (pl)
HR (1) HRP20251425T1 (pl)
MX (1) MX2022009114A (pl)
PL (2) PL3854388T3 (pl)
PT (2) PT3854388T (pl)
SI (1) SI4093383T1 (pl)
WO (1) WO2021148634A1 (pl)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4591622A (en) 1984-10-29 1986-05-27 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product thereof
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
US6337086B1 (en) 1999-02-06 2002-01-08 Dow Corning Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
US9056060B2 (en) 2000-09-19 2015-06-16 Henkel Ag & Co. Kgaa Non-reactive adhesive useful in transdermal drug delivery system
ATE246919T1 (de) 2001-05-08 2003-08-15 Sanol Arznei Schwarz Gmbh Verbessertes transdermales therapeutisches system zur behandlung von morbus parkinson
EP1256339B1 (en) 2001-05-08 2003-10-15 Schwarz Pharma Ag Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
DE10220230A1 (de) 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
EP1386604A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
EP1386605A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10361259A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
NZ584363A (en) 2007-11-28 2012-11-30 Ucb Pharma Gmbh Drug formulations of Rotigotine which comprise the thermodynamically stable polymorphic form 2
CA2726136C (en) 2008-05-30 2016-11-01 Mylan Laboratories, Inc. Stabilized transdermal drug delivery system
EP2298277A1 (en) * 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
LT3257504T (lt) * 2009-12-22 2024-08-26 UCB Biopharma SRL Polivinilpirolidonas, skirtas nekristalinės formos kietos rotigotino dispersijos stabilizavimui
EP2457565A1 (de) 2010-11-29 2012-05-30 Ratiopharm GmbH Transdermales therapeutisches System enthaltend Rotigotin
WO2012084969A1 (en) 2010-12-22 2012-06-28 Hexal Ag Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
US11534523B2 (en) * 2011-08-30 2022-12-27 Avery Dennison Corporation Silicone absorbent adhesive layer
TW201431570A (zh) * 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
US20160199316A1 (en) * 2013-06-14 2016-07-14 Tesa Labtec Gmbh Three-layer transdermal therapy system (tts)
CA2948219C (en) * 2014-05-20 2023-04-04 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
JP7178072B2 (ja) * 2017-02-03 2022-11-25 コスメディ製薬株式会社 ロチゴチン含有経皮吸収型貼付剤
CN109806243B (zh) * 2017-11-20 2022-07-15 北京泰德制药股份有限公司 一种含有氟吡汀或其药用盐的皮肤外用贴剂

Also Published As

Publication number Publication date
ES2966170T3 (es) 2024-04-18
JP7835678B2 (ja) 2026-03-25
BR112022014665A2 (pt) 2022-10-11
EP3854388A1 (de) 2021-07-28
DK4093383T3 (da) 2025-12-01
WO2021148634A1 (de) 2021-07-29
EP4093383B1 (de) 2025-08-27
FI3854388T3 (fi) 2023-11-27
CA3165453A1 (en) 2021-07-29
CN115279351B (zh) 2026-03-10
MX2022009114A (es) 2022-10-27
FI4093383T3 (fi) 2025-11-28
PL3854388T3 (pl) 2024-02-26
AU2021210611A1 (en) 2022-08-18
DK3854388T3 (da) 2023-11-27
SI4093383T1 (sl) 2026-01-30
CL2022001988A1 (es) 2023-05-19
KR20220131941A (ko) 2022-09-29
HRP20251425T1 (hr) 2026-01-30
PT3854388T (pt) 2023-12-11
JP2023511964A (ja) 2023-03-23
ES3051624T3 (en) 2025-12-29
US20230218539A1 (en) 2023-07-13
EP3854388B1 (de) 2023-10-04
CO2022011900A2 (es) 2022-10-31
CN115279351A (zh) 2022-11-01
EP4093383A1 (de) 2022-11-30
PT4093383T (pt) 2025-11-25
AU2021210611B2 (en) 2025-12-18

Similar Documents

Publication Publication Date Title
GB201804502D0 (en) Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings
EP4215126A4 (en) MEDICAL SYSTEM AND MEDICAL DEVICE
EP3769666A4 (en) Human body wearable body information measuring device and medical support system using same
EP3682022A4 (en) HUMAN THERAPEUTIC TARGET MOLECULES AND MODULATORS THEREOF
WO2016149077A3 (en) Fentanyl transdermal delivery system
EP4025972A4 (en) PRETHERAPEUTIC AND THERAPEUTIC DIGITAL MEDICAL DEVICE AND METHOD
EP4316429A4 (en) COVERED STENT AND MEDICAL DEVICE
EP4062847A4 (en) MEDICAL DEVICE AND TREATMENT METHOD
EP4129228A4 (en) MEDICAL DEVICE AND MEDICAL PROGRAM
PL4093383T3 (pl) Transdermalny system terapeutyczny z substancją czynną stanowiącą rotygotynę i co najmniej jednym klejem silikonowym nieodpornym na działanie amin
EP3974795A4 (en) Medical device and medical catheter thereof
EP4442186A4 (en) SHOE CARE DEVICE AND SHOE CARE SET
EP3688716A4 (en) METHOD OF IMPROVING THE COMPLIANCE OF A PATIENT WITH A MEDICAL THERAPY PLAN AND A MOBILE DEVICE TO DO IT
GB2607878B (en) Implantable medical device and assembly
GB2600270B (en) Polymer-comrprising medical devices and uses thereof
GB202309886D0 (en) Silicone polymer skin adhesive
GB2607051B (en) Shoe protector device and applicator
HK40071722A (en) Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive
GB202008980D0 (en) Medical devices and materials
GB202109087D0 (en) Therapeutic methods and devices
HK40042122A (en) Transdermal therapeutic system containing nicotine and silicone acrylic hybrid polymer
AU2020902697A0 (en) Massage therapy devices and techniques
GB2605258B (en) Orthodontic system and applying methods
HK40025980A (en) Transdermal therapeutic system containing scopolamine and silicone acrylic hybrid polymer
HK40101503A (en) Medical penetration device and system